Autoimmune pancreatitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(8 intermediate revisions by the same user not shown)
Line 2: Line 2:
{{Autoimmune pancreatitis}}
{{Autoimmune pancreatitis}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}}{{IQ}}
==Overview==
==Overview==
Autoimmune pancreatitis is a world wide entitiy but it's [[incidence]] has been found to be recently increased in Japan. In North America, 2.5% of pancreatoduodenectomies are done because of AIP being misdiagnosed as [[pancreatic cancer]]. The mean age of patients with AIP is 59 yr (range, 45–75 yr). In autoimmune pancreatitis, the male-to-female ratio was found to be 15:2. Autoimmune pancreatitis usually involves elderly male population.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence:===
*Autoimmune pancreatitis is a world wide entitiy but it's incidence has been found to be recently increased in Japan.<ref name="pmid17182992">{{cite journal |vauthors=Finkelberg DL, Sahani D, Deshpande V, Brugge WR |title=Autoimmune pancreatitis |journal=N. Engl. J. Med. |volume=355 |issue=25 |pages=2670–6 |year=2006 |pmid=17182992 |doi=10.1056/NEJMra061200 |url=}}</ref><ref name="pmid14628815">{{cite journal |vauthors=Okazaki K |title=Autoimmune pancreatitis is increasing in Japan |journal=Gastroenterology |volume=125 |issue=5 |pages=1557–8 |year=2003 |pmid=14628815 |doi= |url=}}</ref><ref name="pmid15057766">{{cite journal |vauthors=Kim KP, Kim MH, Lee SS, Seo DW, Lee SK |title=Autoimmune pancreatitis: it may be a worldwide entity |journal=Gastroenterology |volume=126 |issue=4 |pages=1214 |year=2004 |pmid=15057766 |doi= |url=}}</ref>
*Autoimmune pancreatitis is a world wide entitiy but it's [[incidence]] has been found to be recently increased in Japan.<ref name="pmid17182992">{{cite journal |vauthors=Finkelberg DL, Sahani D, Deshpande V, Brugge WR |title=Autoimmune pancreatitis |journal=N. Engl. J. Med. |volume=355 |issue=25 |pages=2670–6 |year=2006 |pmid=17182992 |doi=10.1056/NEJMra061200 |url=}}</ref><ref name="pmid14628815">{{cite journal |vauthors=Okazaki K |title=Autoimmune pancreatitis is increasing in Japan |journal=Gastroenterology |volume=125 |issue=5 |pages=1557–8 |year=2003 |pmid=14628815 |doi= |url=}}</ref><ref name="pmid15057766">{{cite journal |vauthors=Kim KP, Kim MH, Lee SS, Seo DW, Lee SK |title=Autoimmune pancreatitis: it may be a worldwide entity |journal=Gastroenterology |volume=126 |issue=4 |pages=1214 |year=2004 |pmid=15057766 |doi= |url=}}</ref>


===Prevalence===
===Prevalence:===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
* In Japan, the [[prevalence]] of autoimmune pancreatitis is estimated to be 0.82 per 100 000 inhabitants.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
* In North America, 2.5% of pancreatoduodenectomies are done because of AIP being misdiagnosed as [[pancreatic cancer]].
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Age:===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 
===Age===
*The mean age of patients with AIP is 59 yr (range, 45–75 yr).
*The mean age of patients with AIP is 59 yr (range, 45–75 yr).


===Race===
===Gender:===
*There is no racial predilection to [disease name].
*In autoimmune pancreatitis, the male-to-female ratio was found to be 15:2.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
*Autoimmune pancreatitis usually involves elderly male population.<ref name="pmid11388391">{{cite journal |vauthors=Okazaki K, Uchida K, Chiba T |title=Recent concept of autoimmune-related pancreatitis |journal=J. Gastroenterol. |volume=36 |issue=5 |pages=293–302 |year=2001 |pmid=11388391 |doi= |url=}}</ref><ref name="pmid11923760">{{cite journal |vauthors=Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K |title=ERCP features in 27 patients with autoimmune pancreatitis |journal=Gastrointest. Endosc. |volume=55 |issue=4 |pages=494–9 |year=2002 |pmid=11923760 |doi= |url=}}</ref><ref name="pmid11984513">{{cite journal |vauthors=Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K |title=HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population |journal=Gastroenterology |volume=122 |issue=5 |pages=1264–9 |year=2002 |pmid=11984513 |doi= |url=}}</ref>
===Gender===
*[Disease name] affects men and women equally.
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Latest revision as of 15:43, 5 January 2018

Autoimmune pancreatitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autoimmune pancreatitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines for Management

Case Studies

Case #1

Autoimmune pancreatitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autoimmune pancreatitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autoimmune pancreatitis epidemiology and demographics

CDC on Autoimmune pancreatitis epidemiology and demographics

Autoimmune pancreatitis epidemiology and demographics in the news

Blogs on Autoimmune pancreatitis epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Autoimmune pancreatitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]

Overview

Autoimmune pancreatitis is a world wide entitiy but it's incidence has been found to be recently increased in Japan. In North America, 2.5% of pancreatoduodenectomies are done because of AIP being misdiagnosed as pancreatic cancer. The mean age of patients with AIP is 59 yr (range, 45–75 yr). In autoimmune pancreatitis, the male-to-female ratio was found to be 15:2. Autoimmune pancreatitis usually involves elderly male population.

Epidemiology and Demographics

Incidence:

  • Autoimmune pancreatitis is a world wide entitiy but it's incidence has been found to be recently increased in Japan.[1][2][3]

Prevalence:

  • In Japan, the prevalence of autoimmune pancreatitis is estimated to be 0.82 per 100 000 inhabitants.
  • In North America, 2.5% of pancreatoduodenectomies are done because of AIP being misdiagnosed as pancreatic cancer.

Age:

  • The mean age of patients with AIP is 59 yr (range, 45–75 yr).

Gender:

  • In autoimmune pancreatitis, the male-to-female ratio was found to be 15:2.
  • Autoimmune pancreatitis usually involves elderly male population.[4][5][6]

References

  1. ↑ Finkelberg DL, Sahani D, Deshpande V, Brugge WR (2006). "Autoimmune pancreatitis". N. Engl. J. Med. 355 (25): 2670–6. doi:10.1056/NEJMra061200. PMID 17182992.
  2. ↑ Okazaki K (2003). "Autoimmune pancreatitis is increasing in Japan". Gastroenterology. 125 (5): 1557–8. PMID 14628815.
  3. ↑ Kim KP, Kim MH, Lee SS, Seo DW, Lee SK (2004). "Autoimmune pancreatitis: it may be a worldwide entity". Gastroenterology. 126 (4): 1214. PMID 15057766.
  4. ↑ Okazaki K, Uchida K, Chiba T (2001). "Recent concept of autoimmune-related pancreatitis". J. Gastroenterol. 36 (5): 293–302. PMID 11388391.
  5. ↑ Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K (2002). "ERCP features in 27 patients with autoimmune pancreatitis". Gastrointest. Endosc. 55 (4): 494–9. PMID 11923760.
  6. ↑ Kawa S, Ota M, Yoshizawa K, Horiuchi A, Hamano H, Ochi Y, Nakayama K, Tokutake Y, Katsuyama Y, Saito S, Hasebe O, Kiyosawa K (2002). "HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population". Gastroenterology. 122 (5): 1264–9. PMID 11984513.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Autoimmune_pancreatitis_epidemiology_and_demographics&oldid=1427577"